세계의 약물전달 시장 : 경구 약물전달, 디바이스 유형, 유통 채널, 용도별 예측(2025-2030년)

The Drug Delivery Market was valued at USD 1.72 billion in 2023, expected to reach USD 1.82 billion in 2024, and is projected to grow at a CAGR of 6.41%, to USD 2.65 billion by 2030.

The drug delivery market encompasses a range of technologies aimed at administering therapeutic substances in a controlled manner to achieve specific outcomes. This is crucial for improving drug efficacy, patient compliance, and safety. Drug delivery systems can include advanced methodologies like nanoparticles, liposomes, and hydrogels, alongside traditional mediums such as tablets and injections. The necessity of innovative drug delivery systems stems from the increasing complexity of pharmaceuticals, including biologics and personalized medicine, which require precise targeting and controlled release. Applications span across pharmaceuticals, biotechnology, hospitals, and clinics, with end-use scenarios focusing on chronic disease management, cancer therapy, vaccine delivery, and diagnostics.

The market is significantly influenced by factors such as the rising prevalence of chronic diseases, technological advancements, and increased investment in R&D. Opportunities are emerging through the integration of smart technologies like IoT and AI to create intelligent delivery systems that further enhance precision and monitoring capabilities. Biosensors and bioavailability boosters present promising avenues for development. To capitalize on these opportunities, companies should focus on collaborative partnerships with tech firms and research institutions to innovate next-generation delivery platforms.

However, the market faces limitations from stringent regulatory frameworks and the high cost of developing advanced delivery systems, which can impede smaller companies. Moreover, challenges such as the need for specialized knowledge and the complexity of integrating emerging technologies into existing frameworks also pose significant hurdles. Despite these, areas ripe for innovation include the development of non-invasive delivery methods and personalized drug delivery systems tailored to individual patient profiles, which can significantly enhance adoption rates. Understanding market dynamics and consumer needs will be critical for companies to navigate the shifting landscape successfully. The drug delivery market, characterized by its rapid innovation pace and high investment potential, offers broad opportunities for companies that can overcome regulatory and technological challenges to meet growing demand for efficient and effective treatment solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Delivery Market

The Drug Delivery Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing use of biological drugs worldwide
  • Swelling demand for effective drug delivery mechanisms
  • Significant increase in chronic diseases
• Market Restraints
  • Increasing drug recalls and drug failures
  • Side effects and risk associated with the drugs
• Market Opportunities
  • Rising demand for cost-effective healthcare treatment
  • Growing focus towards home care and self-administration
• Market Challenges
  • Pricing pressure and issues with patents expiry

Porter's Five Forces: A Strategic Tool for Navigating the Drug Delivery Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Delivery Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Delivery Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Delivery Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Delivery Market

A detailed market share analysis in the Drug Delivery Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Delivery Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Delivery Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Delivery Market

A strategic analysis of the Drug Delivery Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Antares Pharma, Inc. by Halozyme Therapeutics, Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Enable Injections, Inc., Gerresheimer AG, Johnson & Johnson Services Inc., Kindeva Drug Delivery, Koninklijke Philips N.V., Merck KGaA, Novartis AG, nsulet Corporation, OraSure Technologies, Inc., Oxford BioMedica PLC, and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Oral Drug Delivery, market is studied across Injectable Drug Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, and Topical Drug Delivery.
• Based on Device Type, market is studied across Advanced and Conventional.
• Based on Distribution Channels, market is studied across Hospital Pharmacies and Retail Pharmacies.
• Based on Application, market is studied across Cancer, Cardiovascular Diseases, Diabetes, and Respiratory Diseases.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing use of biological drugs worldwide
    • 5.1.1.2. Swelling demand for effective drug delivery mechanisms
    • 5.1.1.3. Significant increase in chronic diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Increasing drug recalls and drug failures
    • 5.1.2.2. Side effects and risk associated with the drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising demand for cost-effective healthcare treatment
    • 5.1.3.2. Growing focus towards home care and self-administration
  • 5.1.4. Challenges
    • 5.1.4.1. Pricing pressure and issues with patents expiry
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Drug Delivery Market, by Oral Drug Delivery

• 6.1. Introduction
• 6.2. Injectable Drug Delivery
• 6.3. Nasal Drug Delivery
• 6.4. Ocular Drug Delivery
• 6.5. Pulmonary Drug Delivery
• 6.6. Topical Drug Delivery

7. Drug Delivery Market, by Device Type

• 7.1. Introduction
• 7.2. Advanced
• 7.3. Conventional

8. Drug Delivery Market, by Distribution Channels

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Retail Pharmacies

9. Drug Delivery Market, by Application

• 9.1. Introduction
• 9.2. Cancer
• 9.3. Cardiovascular Diseases
• 9.4. Diabetes
• 9.5. Respiratory Diseases

10. Americas Drug Delivery Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Drug Delivery Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Drug Delivery Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Antares Pharma, Inc. by Halozyme Therapeutics, Inc.
• 2. B. Braun SE
• 3. Baxter International Inc.
• 4. Becton, Dickinson and Company
• 5. Enable Injections, Inc.
• 6. Gerresheimer AG
• 7. Johnson & Johnson Services Inc.
• 8. Kindeva Drug Delivery
• 9. Koninklijke Philips N.V.
• 10. Merck KGaA
• 11. Novartis AG
• 12. nsulet Corporation
• 13. OraSure Technologies, Inc.
• 14. Oxford BioMedica PLC
• 15. Sanofi S.A.